oonal / iStockphoto.com
19 February 2018Americas
Roche to make $1.9bn acquisition
Switzerland-based Roche has revealed plans to acquire a healthcare technology company for $1.9 billion.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
11 May 2018 Eli Lilly has set its sights on Armo BioSciences in a bid to strengthen its immuno-oncology programme.
Americas
20 June 2018 Switzerland-based Roche has agreed to pay $2.4 billion to acquire the remainder of Foundation Medicine, a molecular and genomic analysis company headquartered in Cambridge, Massachusetts.
Americas
25 February 2019 Switzerland-based Roche will buy gene therapy company Spark Therapeutics in a $4.3 billion deal.
Editor's picks
Editor's picks
Americas
11 May 2018 Eli Lilly has set its sights on Armo BioSciences in a bid to strengthen its immuno-oncology programme.
Americas
20 June 2018 Switzerland-based Roche has agreed to pay $2.4 billion to acquire the remainder of Foundation Medicine, a molecular and genomic analysis company headquartered in Cambridge, Massachusetts.
Americas
25 February 2019 Switzerland-based Roche will buy gene therapy company Spark Therapeutics in a $4.3 billion deal.
Americas
11 May 2018 Eli Lilly has set its sights on Armo BioSciences in a bid to strengthen its immuno-oncology programme.
Americas
20 June 2018 Switzerland-based Roche has agreed to pay $2.4 billion to acquire the remainder of Foundation Medicine, a molecular and genomic analysis company headquartered in Cambridge, Massachusetts.
Americas
25 February 2019 Switzerland-based Roche will buy gene therapy company Spark Therapeutics in a $4.3 billion deal.